Institutional Cluster

NKTR

NEKTAR THERAPEUTICS
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago
Institutional cluster: 5 buyers, 0 sellers (bullish)
Actionable Insight • Neutral

The concentrated passive buying is likely index/ETF rebalancing, not a stock-specific thesis. Monitor next 13F for active fund additions or signs of fundamental catalyst. The stock's poor historical performance (0% win rate T+20) suggests caution despite the large inflow.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
NKTR ▲ +25.30% at T+60d
NEUTRAL call ✓ call won +25.30% · α vs SPY +20.90% · entry $59.21 → $74.19
Entry anchored
Jun 11, 05:30 AM ET
via exchange tick
T+1d
+0.29%
call +0.29% · α -0.25%
$59.38
settled 4mo ago
T+5d
+2.89%
call +2.89% · α +2.45%
$60.92
settled 4mo ago
T+20d
+23.15%
call +23.15% · α +21.26%
$72.92
settled 3mo ago
T+60d
+25.30%
call +25.30% · α +20.90%
$74.19
settled 6w ago

Executive Summary

Five mega-passive institutional investors (Vanguard, BlackRock, State Street, Fidelity, Morgan Stanley) significantly increased their NKTR positions in Q3 2025, adding a net $118.0M to holdings. The buying is entirely from passive/index funds, likely reflecting index rebalancing rather than a fundamental catalyst.

Key Financial Metrics

Direction
accumulating
Buy Value
$151.1M
Net Flow
$118.0M

Institutional Positions

Net institutional flow: $118.0M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
VanguardADD+30%$54.0M$35.1M
BlackRockADD+46.7%$34.7M$23.9M
State StreetADD+71.6%$7.3M$6.0M
FidelityDOUBLED+161.6%$2.3M$1.9M
Morgan StanleyDOUBLED+1188%$52.9M$51.0M

Key Facts

  • 5 buyers (all mega-passive), 0 sellers in Q3 2025
  • Total current holdings: $151.1M, net increase of $118.0M
  • Morgan Stanley DOUBLED with +1188% shares to $52.9M
  • Vanguard added +30% to $54.0M; BlackRock +46.7% to $34.7M
  • Fidelity DOUBLED position to $2.3M; State Street +71.6% to $7.3M

Financial Impact

Institutional buying totaling $118.0M, roughly 6% of NKTR's $1.9B market cap

institutional ownershippassive fund inflows

Risk Factors

  • All buying is from passive funds — no active conviction signal
  • NKTR has negative historical returns and poor analyst calibration outcomes
  • Passive inflows may reverse if index composition changes

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-NKTR-2025-Q3
14 reports for NKTR
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +28.57%May 8, 2026
Filters
Rows
Reports for NKTR — sortable, filterable
TypeNow
Aug 13, 2026
9w ago
Press Release
BULLISH ★ 7/10
$73.02 $68.50▼ −6.19%▼ −4.20%—
Aug 9, 2026
10w ago
Institutional Cluster
BULLISH ★ 5/10
$74.86 $75.44▲ +0.77%▲ +1.69%—
Aug 7, 2026
10w ago
Court Ruling
NEUTRAL ★ 4/10
$76.48 $74.19▼ −2.99%▼ −2.60%—
Jul 28, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$70.68 $73.77▲ +4.37%▼ −0.65%—
Jun 11, 2026
18w ago
Institutional Cluster
MIXED ★ 4/10
$59.21 $72.92▲ +23.15%▲ +21.26%—
Jun 11, 2026
18w ago
Institutional Cluster
NEUTRAL ★ 3/10
$59.21 $72.92▲ +23.15%▲ +21.26%—
May 21, 2026
21w ago
Insider Cluster
BEARISH ★ 5/10
$66.61 $65.25▲ +2.04%▲ +0.63%—
May 8, 2026
23w ago
8-K
BEARISH ★ 5/10
$78.72 $56.23▲ +28.57%▲ +28.27%—
May 7, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$81.89 $57.32▼ −30.00%▼ −30.03%—
Apr 24, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$86.74 $65.56▼ −24.42%▼ −29.37%—
Showing 10 of 14

US Market Status

Market Closed — Opens in 30m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026